Gilles has 35 years of experience in the pharmaceutical and biotechnology sectors. He created and developed OPi, Pharmaceuticals for Rare Diseases and has taken more than ten products through clinical trials.
Julien is a graduate of EM LYON Business School and IAE Lyon management school. He is the funder and the Chief Executive Officer of Mathym since 2013, a nanotechnology company acquired in 2019 by Baikowski SA, of which he is also the Business Development Director.
Jeremy is a pharmacist and oncologist, who specialises in immuno-oncology. He joined initiative OCTALFA and Orega Biotech in 2010 and Orphelia Pharma in 2015. He is Chief Executive Officer of OREGA Biotech.
Charlotte joined initiative OCTALFA in October 2016 as an executive assistant. Charlotte is also responsible for the administrative management of the Foundation’s projects, for which she is also administrator representing the company’s employees.
Thuy Linh joined initiative OCTALFA in December 2018. She holds a master’s degree in Business Law and is involved in all legal subjects of OCTALFA and its subsidiaries. She also participates in monitoring the different administrative and financial subjects.
Trained as a chartered accountant completed by EM-Lyon MBA and having held CFO and General Management positions in several French SMEs, Rémi joined us in 2022 to manage the administrative and financial aspects of the OCTALFA group, including subsidiaries and charitable activities.